DeMarte J - Search Results

1

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and beta-ionylideneacetamidobenzoates with retinoidal activity.

Jones P, Villeneuve GB, Fei C, DeMarte J, Haggarty AJ, Nwe KT, Martin DA, Lebuis AM, Finkelstein JM, Gour-Salin BJ, Chan TH, Leyland-Jones BR. Jones P, et al. Among authors: demarte j. J Med Chem. 1998 Jul 30;41(16):3062-77. doi: 10.1021/jm9801354. J Med Chem. 1998. PMID: 9685246

2

Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3.

Jean-Claude BJ, Mustafa A, Damian Z, De Marte J, Vasilescu DE, Yen R, Chan TH, Leyland-Jones B. Jean-Claude BJ, et al. Biochem Pharmacol. 1999 Apr 1;57(7):753-62. doi: 10.1016/s0006-2952(98)00345-1. Biochem Pharmacol. 1999. PMID: 10075081

3

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro.

Jean-Claude BJ, Mustafa A, Cetateanu ND, Damian Z, De Marte J, Yen R, Vasilescu D, Chan TH, Leyland-Jones B. Jean-Claude BJ, et al. Br J Cancer. 1997;76(4):467-73. doi: 10.1038/bjc.1997.411. Br J Cancer. 1997. PMID: 9275023 Free PMC article.

4

Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells.

Jean-Claude BJ, Mustafa A, Damian Z, De Marte J, Vasilescu DE, Yen R, Chan TH, Leyland-Jones B. Jean-Claude BJ, et al. Cancer Chemother Pharmacol. 1998;42(1):59-67. doi: 10.1007/s002800050785. Cancer Chemother Pharmacol. 1998. PMID: 9619759

5

A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS).

Beaulieu PL, De Marte J, Garneau M, Luo L, Stammers T, Telang C, Wernic D, Kukolj G, Duan J. Beaulieu PL, et al. Bioorg Med Chem Lett. 2015 Jan 15;25(2):210-5. doi: 10.1016/j.bmcl.2014.11.071. Epub 2014 Dec 4. Bioorg Med Chem Lett. 2015. PMID: 25515558

6

Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor.

Duan J, Yong CL, Garneau M, Amad M, Bolger G, De Marte J, Montpetit H, Otis F, Jutras M, Rhéaume M, White PW, Llinàs-Brunet M, Bethell RC, Cordingley MG. Duan J, et al. Xenobiotica. 2012 Feb;42(2):164-72. doi: 10.3109/00498254.2011.611546. Epub 2011 Oct 11. Xenobiotica. 2012. PMID: 21988548

7

Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence.

Duan J, Paris W, De Marte J, Roopchand D, Fleet TL, Cordingley MG. Duan J, et al. Antiviral Res. 2000 May;46(2):135-44. doi: 10.1016/s0166-3542(00)00080-2. Antiviral Res. 2000. PMID: 10854665

8

A novel model of HPV infection in meshed human foreskin grafts.

Duan J, De Marte J, Paris W, Roopchand D, Fleet TL, Clarke JA, Yeong SH, Ferenczy A, Katz M, Cordingley MG. Duan J, et al. Antiviral Res. 2004 Dec;64(3):179-88. doi: 10.1016/j.antiviral.2004.08.004. Antiviral Res. 2004. PMID: 15550271

9

Endothelin-1 has a dilator effect on neonatal pig pulmonary vasculature.

Perreault T, De Marte J. Perreault T, et al. J Cardiovasc Pharmacol. 1991 Jul;18(1):43-50. doi: 10.1097/00005344-199107000-00007. J Cardiovasc Pharmacol. 1991. PMID: 1719291

10

Ontogeny of Big endothelin-1 effects in newborn piglet pulmonary vasculature.

Liben S, Stewart DJ, De Marte J, Perreault T. Liben S, et al. Am J Physiol. 1993 Jul;265(1 Pt 2):H139-45. doi: 10.1152/ajpheart.1993.265.1.H139. Am J Physiol. 1993. PMID: 8342625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters